Reducing the Burden and Transforming Outcomes for Patients With Beta Thalassemia

Name: Reducing the Burden and Transforming Outcomes for Patients With Beta Thalassemia
Availability: InStock

Beta thalassemia care is being redefined by gene editing and novel disease-modifying agents. Join experts Dr. Al-Samkari and Dr. Badawy as they explore evidence-based strategies to reduce treatment burden, master iron chelation, and transform outcomes. Start the case consult now!